BIAF

bioAffinity Technologies, Inc.

BIAF · CIK 0001712762 · Annual (10-K) · Last 3 years

Financial Trends

Revenue$9M
20222024
Net Income−$9M
20222024
Operating CF−$7M
20222024
Free Cash Flow−$7M
20222024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕
Revenue$0.0B$0.0B$0.0B
Cost of Revenue——$0.0B
Gross Profit——$0.0B
R&D Expense$0.0B$0.0B$0.0B
SG&A Expense$0.0B$0.0B$0.0B
Operating Income$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B
EPS (Basic)$-0.75$-0.91$-1.81
EPS (Diluted)$-0.75$-0.91—

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕
Total Assets$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$-0.0B$0.0B
← Companies